Clinical Trial Update: Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating efficacy and safety in male subjects with premature ejaculation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Premature Ejaculation | Phase 3 | Status: TERMINATED